IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Insight Brief
Valuing the Patient Voice in Medicines Access Decisions - How Does Australia Compare?
Apr 21, 2026
How does Australia compare internationally on incorporating the patient voice into health technology assessment (HTA)? This brief benchmarks Australia against Canada, France, Germany and the UK over the last decade, and clarifies the difference between consumer input (lived experience) and consumer evidence (including patient‑reported outcomes and real‑world evidence). It highlights where Australia is ahead, where it lags, and practical opportunities to strengthen patient‑informed evidence in medicines access decision‑making.
Related solutions
Real World Evidence
Health Economics and Value
Access clearer, more compelling support to demonstrate the value of your product.
Market Access Insights
Market Access Insights provides access to HTA, reimbursement, regulatory, clinical trial, and pricing information so that you can make more informed market access decisions.
HTA Accelerator
A clearer path to market access
